StockNews.com initiated coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report sent to investors on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance PIRS opened at $0.23 on Monday. The firm’s 50-day simple moving average is $0.28 and its 200-day simple moving […]
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Pieris Pharmaceuticals Stock Performance Shares of PIRS opened at $0.28 on Friday. Pieris Pharmaceuticals has a 1 year low of $0.16 and a 1 […]
Pieris Pharmaceuticals (NASDAQ:PIRS) Now Covered by StockNews com kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a report published on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock. Separately, William Blair lowered shares of Pieris Pharmaceuticals from an outperform rating to a market perform rating in a research report on Wednesday, June 21st. […]
StockNews.com began coverage on shares of Pieris Pharmaceuticals (NASDAQ:PIRS – Free Report) in a research report released on Monday. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, William Blair cut Pieris Pharmaceuticals from an outperform rating to a market perform rating in a report on Wednesday, June 21st. View Our Latest […]